Modunai Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Modunai Therapeutics General Information
Description
Developer of bispecifics and antibody-drug conjugates designed for targeting stress pathways to eliminate residual disease and deliver durable outcomes for cancer patients. The company is currently operating in Stealth mode.
Contact Information
Website
www.modunaitherapeutics.comCorporate Office
- Boston, MA
- United States
Corporate Office
- Boston, MA
- United States
Modunai Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 30-Oct-2025 | Completed | Stealth |
Modunai Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bioincubator | Accelerator/Incubator |
Modunai Therapeutics FAQs
-
Where is Modunai Therapeutics headquartered?
Modunai Therapeutics is headquartered in Boston, MA.
-
What industry is Modunai Therapeutics in?
Modunai Therapeutics’s primary industry is Drug Delivery.
-
Is Modunai Therapeutics a private or public company?
Modunai Therapeutics is a Private company.
-
What is Modunai Therapeutics’s current revenue?
The current revenue for Modunai Therapeutics is .
-
Who are Modunai Therapeutics’s investors?
Bioincubator has invested in Modunai Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process